Skip to main content
Log in

Compliance and Outcomes in Patients with Asthma

  • Published:
Drugs Aims and scope Submit manuscript

Summary

The severity of asthma varies within and between individuals, and the disease has a variable impact on quality of life. Disease severity can be modified but not cured by long term anti-inflammatory therapy. Compliance with, or adherence to, such therapeutic regimens is difficult, and it is affected by a number of factors. Patterns of compliance are variable; some patients take only half the prescribed drug all the time, while others take all their prescribed medication for a while and then ‘take a break’. Understandably, there is no single factor that would account for such a variety of human behaviour, but generally the frequency and ease of drug administration, as well as adverse effects (real or imagined), can affect compliance. Poor communication regarding the precise regimen will also impair compliance.

Psychosocial factors such as depression, poor interpersonal skills and coping strategies, and rejection of the diagnosis will lead to lower levels of compliance. Interventional programmes using a combination of education, skills training and methods to modify behaviour are needed to improve the quality of life in asthmatics. The role of the newer generations of once-/twice-daily oral anti-inflammatory preparations in improving compliance requires further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Clin Immunol 1989; 83: 1013–25

    Article  CAS  Google Scholar 

  2. Guidelines on the Management of Asthma. British Thoracic Society, British Paediatric Association, Royal College of General Practitioners. Thorax 1993; 48 Suppl.: S1–24

    Article  Google Scholar 

  3. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, Oct 1992. Am Rev Respir Dis 1993; 148 Suppl. 4: S1–26

    PubMed  CAS  Google Scholar 

  4. Toogood JH, Baskervillle J, Jennings B. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid budesonide. J Allergy Clin Immunol 1982; 70: 288–9

    Article  PubMed  CAS  Google Scholar 

  5. Horn CR, Clark TJH, Cochrane GM. Can the morbidity of asthma be reduced by high dose inhaled therapy? A prospective study. Respir Med 1990; 84: 61–6

    Article  PubMed  CAS  Google Scholar 

  6. Jones PW. Quality of life, health economics and asthma. Eur Respir Rev 1995; 5 (Rev. 30): 279–83

    Google Scholar 

  7. Juniper EF, Guyatt GM, Ferrie PJ, et al. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832–8

    PubMed  CAS  Google Scholar 

  8. Horn CR, Clark TJH, Cochrane GM. Compliance with inhaled therapy and morbidity from asthma. Respir Med 1990; 84: 67–70

    Article  PubMed  CAS  Google Scholar 

  9. Sackett DL. The magnitude of compliance with non-compliance. In: Sackett DL, Taylor DW, Haynes RB, editors. Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press, 1979: 323–5

    Google Scholar 

  10. Cochrane GM. Compliance in asthma. Eur Respir Rev 1995; 5(26): 116–9

    Google Scholar 

  11. Spector SL. Is your asthmatic really complying? Ann Allergy 1985; 55: 552–6

    PubMed  CAS  Google Scholar 

  12. Rand CS, Wise RA, Nides M, et al. Metered dose inhaler adherence in clinical trials. Am Rev Respir Dis 1992; 146: 1559–64

    PubMed  CAS  Google Scholar 

  13. Cochrane GM, Bosley C. Compliance with inhaled therapy in asthma. Eur Respir Rev 1994; 18: 92–4

    Google Scholar 

  14. Chowienczyk PJ, Lawson CP, Harris J, et al. Electronic diary card to record physiological measurements. Lancet 1992; 339: 251

    Article  PubMed  CAS  Google Scholar 

  15. Hyland ME, Kenyon CAP, Allen R, et al. Diary keeping in asthma — comparison of the written and electronic methods. BMJ 1993; 306: 487–9

    Article  PubMed  CAS  Google Scholar 

  16. Levine RJ. Monitoring for adherence — ethical considerations [editorial]. Am J Crit Care Med 1994; 149: 287–8

    CAS  Google Scholar 

  17. Yeung M, O’Connor SA, Cochrane GM. Compliance with prescribed drug therapy and the management of asthma. Respir Med 1994; 88: 31–5

    Article  PubMed  CAS  Google Scholar 

  18. Kossoy AF, Hill M, Lin FL, et al. Are theophylline ‘levels’ a reliable indicator of compliance? J Allergy Clin Immunol 1989; 84: 60–5

    Article  PubMed  CAS  Google Scholar 

  19. Hendeles L, Massanari M, Weinberg M. Theophylline. In: Middleton EJ, Reed CE, Ellis EF et al., editors. Allergy principles and practice. 3rd ed. St Louis: The CV Mosley Co, 1988: 673–714

    Google Scholar 

  20. Eney RD, Goldstein EO. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. Paediatrics 1976; 57: 513–7

    CAS  Google Scholar 

  21. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment approach. JAMA 1989; 261: 3273–7

    Article  PubMed  CAS  Google Scholar 

  22. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance [see comments]. Arch Intern Med 1990; 150: 1881–4. Comment in: Arch Intern Med 1991; 151 (6): 1236–7

    Google Scholar 

  23. Spector SL, Kinzman R, Mawhinney H, et al. Compliance of patients with an experimental aerosolised medication: implications for controlled trials. J Allerg Clin Immunol 1986; 77: 65–70

    Article  CAS  Google Scholar 

  24. Mann M, Eliasson A, Patel K, et al. A comparison of the effects of b.i.d. and q.i.d. dosing on compliance with inhaled flunizolide. Chest 1992; 101: 496–9

    Article  PubMed  CAS  Google Scholar 

  25. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992; 146: 1559–64

    PubMed  CAS  Google Scholar 

  26. Dompeling E, Von Grunsven PM, VanSchayck CP, et al. Treatment with inhaled steroids in asthma and chronic bronchitis. Long term compliance and inhaler technique. Fam Pract 1992; 9(2): 161–6

    Article  PubMed  CAS  Google Scholar 

  27. Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication. Does combining beta agonist with corticosteroids improve compliance? Eur Respir J 1994; 7: 504–9

    CAS  Google Scholar 

  28. Crompton GK. The adult patients’ difficulties with inhalers. Lung 1990; 168 Suppl.: 658–62

    Article  PubMed  Google Scholar 

  29. Worth H. Patient education in asthmatic adults. Lung 1990; 168 Suppl.: 463–8

    Article  PubMed  Google Scholar 

  30. Brewis RAL. Patient education, self management plans and peak flow measurement. Respir Med 1991; 85: 457–62

    Article  PubMed  CAS  Google Scholar 

  31. Osman LM, Russell IT, Friend JR, et al. Predicting patients’ attitudes to asthma medication. Thorax 1993; 48: 827–30

    Article  PubMed  CAS  Google Scholar 

  32. Mayo PH, Richman J, Harris HW. Results of a programme to reduce admissions for adult asthma. Arch Intern Med 1990; 112: 864–71

    CAS  Google Scholar 

  33. Sibbald B. Patient self care in acute asthma. Thorax 1989; 44: 97–101

    Article  PubMed  CAS  Google Scholar 

  34. Osman L. The patient perspective: what should a new anti-asthma agent provide? Drugs. In press

  35. Hayes-Baulista DE. Modifying the treatment: patient compliance, patient control and medical care. Soc Sci Med 1976; 10: 233–8

    Article  Google Scholar 

  36. Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979: 49–62

    Google Scholar 

  37. Blackwell B, Gutmann MC. Compliance. In: Bilpott CJ, editor. Handbook of hypertension. Vol. 6. Epidemiology of hypertension. Amsterdam: Elsevier Science Publishers BV, 1985: 453–72

    Google Scholar 

  38. Palo VA, Mayr PH, Friedman P. Demographic influences in asthma hospital admission rates in New York City. Chest 1994; 106: 447–51

    Article  PubMed  Google Scholar 

  39. Bosley C, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995; 8: 899–904

    PubMed  CAS  Google Scholar 

  40. Rand CS, Nides M, Cowles MK, et al. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med 1995; 152: 580–8

    PubMed  CAS  Google Scholar 

  41. Yellowless PM, Haynes S, Potts N, et al. Psychiatric morbidity in patients with life threatening asthma: initial report of a controlled study. Med J Aust 1988; 149: 246–9

    Google Scholar 

  42. Kinsman RA, Dukes JF, Jones NF, et al. Anxiety reduction in asthma: four catches to general application. Psychosom Med 1980; 42(4): 397–405

    PubMed  CAS  Google Scholar 

  43. Bosley CM, Fosbury JA, Cochrane GM. Psychological factors associated with poor patient compliance with inhaled treatment in asthma. Am J Respir Crit Care 1994; 149(4): A248

    Google Scholar 

  44. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch Int Med 1994; 154: 1349–53

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacCochrane, G. Compliance and Outcomes in Patients with Asthma. Drugs 52 (Suppl 6), 12–19 (1996). https://doi.org/10.2165/00003495-199600526-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199600526-00004

Keywords

Navigation